Sclerosing encapsulating peritonitis and methotrexate.
Sachdev
A
A
The Alfred Hospital, Melbourne, Australia. anish400@hotmail.com
Usatoff
V
V
Thaow
C
C
D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy; D007249:Inflammation; D007813:Laparotomy; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D010538:Peritonitis / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D011247:Pregnancy; D012598:Sclerosis; D014594:Uterine Neoplasms / Q000188:drug therapy
D000020:Abortifacient Agents, Nonsteroidal; D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate